Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-05-04
1979-03-27
Evans, Joseph E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
562433, 562448, 562556, 562560, 562564, 562575, A61K 31195, C07C10104, C07C10126, C07C10130
Patent
active
041466411
ABSTRACT:
New carboxyalkylacylamino acids which have the general formula ##STR1## are useful as angiotensin converting enzyme inhibitors.
REFERENCES:
patent: 3462535 (1969-08-01), Loer et al.
patent: 3551419 (1970-12-01), Re et al.
patent: 3852338 (1974-12-01), Kaiser et al.
patent: 3896166 (1975-07-01), Kaiser et al.
Cushman David W.
Ondetti Miguel A.
E. R. Squibb & Sons Inc.
Evans Joseph E.
Levinson Lawrence S.
Smith Merle J.
LandOfFree
Carboxyalkylacylamino acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carboxyalkylacylamino acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carboxyalkylacylamino acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1822235